Kwality Pharmaceuticals Limited submitted a regulatory disclosure to the BSE Limited regarding an investor meeting outcome. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A Knowledge Session (Virtual Interaction) for Investors was organized by Go India Advisors on behalf of the company. The meeting was held on Monday, 10th August, 2026 at 4:00 P.M. (IST).
During the interaction, the management discussed the company's business operations, performance, and outlook. The discussion was based solely on publicly available information. The company explicitly stated that no unpublished price sensitive information (UPSI) was shared or discussed during the meeting.
The audio/video recording of the meeting is available for access at: https://www.kwalitypharma.com/Schedule%20of%20Analysts%20or%20Institutional%20Investors%20meet%20and%20Presentations%20made%20to%20them.php
The document was digitally signed by Ramesh Kumar, Managing Director (DIN: 00462656), on August 12, 2026 at 15:26:07 IST.